Atlanta Consulting Group Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Sell
1,568
-241
-13% -$66.7K 0.05% 142
2026
Q1
$534K Buy
1,809
+487
+37% +$145K 0.11% 89
2025
Q4
$361K Sell
1,322
-782
-37% -$212K 0.08% 113
2025
Q3
$569K Buy
2,104
+225
+12% +$61.2K 0.14% 76
2025
Q2
$518K Hold
1,879
0.14% 73
2025
Q1
$499K Sell
1,879
-560
-23% -$138K 0.15% 70
2024
Q4
$566K Sell
2,439
-247
-9% -$56.8K 0.21% 69
2024
Q3
$593K Buy
2,686
+247
+10% +$51.1K 0.15% 120
2024
Q2
$480K Hold
2,439
0.1% 75
2024
Q1
$525K Buy
+2,439
New +$512K 0.18% 70

Other funds holding CME

Atlanta Consulting Group Advisors's CME Position: Q2 2026 in Review

Atlanta Consulting Group Advisors reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $66.7K and leaving 1,568 shares worth $346K. The position accounts for 0.05% of the portfolio, ranked #142.

Atlanta Consulting Group Advisors first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $593K in Q3 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Atlanta Consulting Group Advisors held 1,568 shares of CME Group worth $346K as of Q2 2026.
  • Atlanta Consulting Group Advisors sold 241 CME Group shares in Q2 2026, an estimated $66.7K.
  • CME Group made up 0.05% of Atlanta Consulting Group Advisors's portfolio in Q2 2026, its #142 holding.
  • Atlanta Consulting Group Advisors first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Atlanta Consulting Group Advisors's CME Group position peaked at $593K in Q3 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.